Patent Assignment
Reel/Frame 024147/0953
Assignment of Assignor's Interest
Recorded: 2010-03-26
Pages: 4
Assignee
CORUS PHARMA, INC.
2025 FIRST AVENUE, SUITE 800, SEATTLE, WASHINGTON, 98121
Covered Property
(1)
Inhalable Aztreonam Lysinate Formulation for Treatment and Prevention of Pulmonary Bacterial Infections
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.